Aspira Pathlab Approves ₹65 Crore Rights Issue Subject To Approvals

Board approved raising up to Rs65 crore via rights issue of equity or convertibles to eligible shareholders, subject to shareholder and regulatory approvals, and formed Rights Issue Committee for price, ratio and record date. Context: first dilution after years without equity raise, reviving last month's deferred plan.